Steady-state flux and lag time in the stratum corneum lipid pathway: results from finite element models
Finite element model (FEM) solutions of the diffusion through two-dimensional representations of the stratum corneum (SC) lipid pathway are presented. Both simplified, regular "brick and mortar" models and a more complex, irregular model are analyzed. It is assumed that diffusion occurs on...
Saved in:
| Published in: | Journal of pharmaceutical sciences Vol. 92; no. 11; p. 2196 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.11.2003
|
| Subjects: | |
| ISSN: | 0022-3549 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Finite element model (FEM) solutions of the diffusion through two-dimensional representations of the stratum corneum (SC) lipid pathway are presented. Both simplified, regular "brick and mortar" models and a more complex, irregular model are analyzed. It is assumed that diffusion occurs only within the SC lipids and the lipids are isotropic. The steady-state flux and lag time are solved and compared with the corresponding values for a homogeneous membrane of the same thickness consisting of lipid material. Results confirm that the heterogeneous SC model behaves like a homogeneous membrane, meaning that FEM diffusion simulations are well approximated by an appropriate solution of the diffusion equation for a homogeneous membrane. Additionally, both steady-state flux and lag time (relative to these values in a homogeneous membrane) can be predicted from algebraic equations based on simple dimensionless descriptors of SC geometry. However, values for diffusivity derived from homogeneous membrane approximations to the FEM solutions (effective diffusivity, D*) are not equal to the intrinsic diffusivity of the chemical in lipid. Furthermore, the pathlength derived from homogeneous membrane approximations to FEM solutions (effective pathlength, l*) is not equal to the lipid pathlength and is not dependent on SC tortuosity. Whereas l* is not a function of corneocyte overlap, D* is. These model results suggest that diffusion properties of the SC lipid pathway can be correlated to SC geometry, but intrinsic diffusion coefficients and SC tortuosity cannot be derived from common diffusion cell experiments. Use of the model equations to predict permeability and lag time of lipophilic solutes is described. |
|---|---|
| AbstractList | Finite element model (FEM) solutions of the diffusion through two-dimensional representations of the stratum corneum (SC) lipid pathway are presented. Both simplified, regular "brick and mortar" models and a more complex, irregular model are analyzed. It is assumed that diffusion occurs only within the SC lipids and the lipids are isotropic. The steady-state flux and lag time are solved and compared with the corresponding values for a homogeneous membrane of the same thickness consisting of lipid material. Results confirm that the heterogeneous SC model behaves like a homogeneous membrane, meaning that FEM diffusion simulations are well approximated by an appropriate solution of the diffusion equation for a homogeneous membrane. Additionally, both steady-state flux and lag time (relative to these values in a homogeneous membrane) can be predicted from algebraic equations based on simple dimensionless descriptors of SC geometry. However, values for diffusivity derived from homogeneous membrane approximations to the FEM solutions (effective diffusivity, D*) are not equal to the intrinsic diffusivity of the chemical in lipid. Furthermore, the pathlength derived from homogeneous membrane approximations to FEM solutions (effective pathlength, l*) is not equal to the lipid pathlength and is not dependent on SC tortuosity. Whereas l* is not a function of corneocyte overlap, D* is. These model results suggest that diffusion properties of the SC lipid pathway can be correlated to SC geometry, but intrinsic diffusion coefficients and SC tortuosity cannot be derived from common diffusion cell experiments. Use of the model equations to predict permeability and lag time of lipophilic solutes is described. Finite element model (FEM) solutions of the diffusion through two-dimensional representations of the stratum corneum (SC) lipid pathway are presented. Both simplified, regular "brick and mortar" models and a more complex, irregular model are analyzed. It is assumed that diffusion occurs only within the SC lipids and the lipids are isotropic. The steady-state flux and lag time are solved and compared with the corresponding values for a homogeneous membrane of the same thickness consisting of lipid material. Results confirm that the heterogeneous SC model behaves like a homogeneous membrane, meaning that FEM diffusion simulations are well approximated by an appropriate solution of the diffusion equation for a homogeneous membrane. Additionally, both steady-state flux and lag time (relative to these values in a homogeneous membrane) can be predicted from algebraic equations based on simple dimensionless descriptors of SC geometry. However, values for diffusivity derived from homogeneous membrane approximations to the FEM solutions (effective diffusivity, D*) are not equal to the intrinsic diffusivity of the chemical in lipid. Furthermore, the pathlength derived from homogeneous membrane approximations to FEM solutions (effective pathlength, l*) is not equal to the lipid pathlength and is not dependent on SC tortuosity. Whereas l* is not a function of corneocyte overlap, D* is. These model results suggest that diffusion properties of the SC lipid pathway can be correlated to SC geometry, but intrinsic diffusion coefficients and SC tortuosity cannot be derived from common diffusion cell experiments. Use of the model equations to predict permeability and lag time of lipophilic solutes is described.Finite element model (FEM) solutions of the diffusion through two-dimensional representations of the stratum corneum (SC) lipid pathway are presented. Both simplified, regular "brick and mortar" models and a more complex, irregular model are analyzed. It is assumed that diffusion occurs only within the SC lipids and the lipids are isotropic. The steady-state flux and lag time are solved and compared with the corresponding values for a homogeneous membrane of the same thickness consisting of lipid material. Results confirm that the heterogeneous SC model behaves like a homogeneous membrane, meaning that FEM diffusion simulations are well approximated by an appropriate solution of the diffusion equation for a homogeneous membrane. Additionally, both steady-state flux and lag time (relative to these values in a homogeneous membrane) can be predicted from algebraic equations based on simple dimensionless descriptors of SC geometry. However, values for diffusivity derived from homogeneous membrane approximations to the FEM solutions (effective diffusivity, D*) are not equal to the intrinsic diffusivity of the chemical in lipid. Furthermore, the pathlength derived from homogeneous membrane approximations to FEM solutions (effective pathlength, l*) is not equal to the lipid pathlength and is not dependent on SC tortuosity. Whereas l* is not a function of corneocyte overlap, D* is. These model results suggest that diffusion properties of the SC lipid pathway can be correlated to SC geometry, but intrinsic diffusion coefficients and SC tortuosity cannot be derived from common diffusion cell experiments. Use of the model equations to predict permeability and lag time of lipophilic solutes is described. |
| Author | Frasch, H Frederick Barbero, Ana M |
| Author_xml | – sequence: 1 givenname: H Frederick surname: Frasch fullname: Frasch, H Frederick email: hbf9@cdc.gov organization: Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, West Virginia 26505, USA. hbf9@cdc.gov – sequence: 2 givenname: Ana M surname: Barbero fullname: Barbero, Ana M |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/14603505$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kE1LAzEYhHOo2A89-AckJ2-r-dikrjcpVoWCB_W8vN28aVOS7LrJov33LlhhYGZgeA4zJ5PYRiTkirNbzpi4O3RpDKXWEzIbuyikKqspmad0YIxpptQ5mfJSM6mYmpHde0YwxyJlyEitH34oREM97Gh2AamLNO-RptxDHgJt2j7i6N51ztAO8v4bjg-0xzT4nKjt20Cti25koceAMdPQGvTpgpxZ8AkvT74gn-unj9VLsXl7fl09bopGVkoXpdAg7wVqq0BDZVEZKdGM2nJslkyXVcmM3PJGS4FLAxXjnNnGaGYlaCMW5OaP2_Xt14Ap18GlBr2HiO2Q6iWXUojxlwW5Pg2HbUBTd70L0B_r_2vELwXoZgU |
| CitedBy_id | crossref_primary_10_1002_jps_21035 crossref_primary_10_1016_j_compchemeng_2020_106976 crossref_primary_10_3390_pharmaceutics8030021 crossref_primary_10_1016_j_xphs_2023_03_002 crossref_primary_10_1002_jps_24669 crossref_primary_10_1063_5_0121578 crossref_primary_10_1016_j_jconrel_2015_08_023 crossref_primary_10_1002_jps_20883 crossref_primary_10_1016_j_ces_2008_08_021 crossref_primary_10_1088_0022_3727_45_2_025301 crossref_primary_10_2147_IJN_S261386 crossref_primary_10_1016_j_eml_2021_101327 crossref_primary_10_1016_j_ijpharm_2011_02_023 crossref_primary_10_1177_026119290703500124 crossref_primary_10_1016_j_comtox_2023_100267 crossref_primary_10_1016_j_ijpharm_2019_118547 crossref_primary_10_1016_j_addr_2012_10_009 crossref_primary_10_1016_j_mbs_2008_11_004 crossref_primary_10_1016_j_ijthermalsci_2011_10_022 crossref_primary_10_1016_j_ces_2020_115729 crossref_primary_10_1016_j_xphs_2017_09_015 crossref_primary_10_1016_j_addr_2012_04_011 crossref_primary_10_1093_toxsci_kfj014 crossref_primary_10_1016_j_xphs_2018_11_014 crossref_primary_10_1002_jps_20776 crossref_primary_10_1016_j_comtox_2019_02_004 crossref_primary_10_1002_jps_20896 crossref_primary_10_1007_s11095_009_9849_7 crossref_primary_10_1007_s11538_007_9197_x crossref_primary_10_1007_s11095_010_0191_x crossref_primary_10_1016_j_envres_2020_109307 crossref_primary_10_1016_j_xphs_2016_08_010 crossref_primary_10_1016_j_addr_2012_01_001 crossref_primary_10_1002_jps_20497 crossref_primary_10_1002_jps_20695 crossref_primary_10_1016_j_jconrel_2025_113773 crossref_primary_10_1111_ics_12656 crossref_primary_10_1007_s10439_009_9678_1 crossref_primary_10_1002_jps_20509 crossref_primary_10_1007_s00791_006_0017_x crossref_primary_10_1007_s10439_005_5591_4 crossref_primary_10_1002_jps_20549 crossref_primary_10_1016_j_addr_2012_04_009 crossref_primary_10_1186_1742_4682_7_33 crossref_primary_10_1016_j_ejpb_2007_05_018 crossref_primary_10_1016_j_jconrel_2013_12_005 crossref_primary_10_1016_j_addr_2012_04_003 crossref_primary_10_1093_toxsci_kfl048 |
| ContentType | Journal Article |
| Copyright | Copyright 2003 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 92:2196-2207, 2003 |
| Copyright_xml | – notice: Copyright 2003 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 92:2196-2207, 2003 |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1002/jps.10466 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| ExternalDocumentID | 14603505 |
| Genre | Journal Article |
| GroupedDBID | --- -~X .3N .GA .GJ .Y3 05W 0R~ 10A 1CY 1L6 1OC 1ZS 31~ 33P 36B 3O- 3WU 4.4 457 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 A8Z AAEVG AAHHS AAKUH AALRI AANHP AAOIN AAONW AAXUO AAYOK AAZKR ABCQN ABEML ABFRF ABIJN ABJNI ABMAC ABOCM ABPVW ACBWZ ACCFJ ACGFO ACGFS ACIWK ACPRK ACRPL ACSCC ACXQS ACYXJ ADBBV ADIZJ ADNMO ADVLN AEEZP AEFWE AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFJKZ AFRAH AFTJW AFZJQ AGHFR AI. AITUG AIWBW AJAOE AJBDE AKRWK ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR AMRAJ ATUGU AZBYB BAFTC BDRZF BNHUX BROTX BRXPI BY8 CGR CS3 CUY CVF D-E D-F DCZOG DPXWK DR2 DU5 E3Z EBD EBS ECM EIF EJD EMB EMOBN F00 F01 F04 F5P FDB FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HHY HHZ HOLLA HVGLF HX~ HZ~ IX1 J0M JPC KQQ L7B LAW LC2 LC3 LH4 LP6 LP7 LSO LW6 M41 M6Q MK0 MK4 N04 N05 N9A NF~ NNB NPM O66 O9- OIG P2P P2X P4D Q.N Q11 QB0 QRW R.K RNS ROL RWI RX1 RYL SSZ SUPJJ SV3 UB1 UKR UNMZH V2E V8K VH1 VXZ W8V W99 WBFHL WH7 WIB WJL WQJ WRC WUP WWP WYUIH XG1 XPP XV2 Y6R YCJ Z5M ZE2 ZGI ZXP ~IA ~WT 7X8 AAMMB AEFGJ AGQPQ AGXDD AIDQK AIDYY EFKBS |
| ID | FETCH-LOGICAL-c3956-426a382e6f5a6a9fe5d33ed3edb1ec7064940d3b1c632e7da90110fcd60f3a6d2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 66 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000186556800006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0022-3549 |
| IngestDate | Wed Oct 01 13:48:07 EDT 2025 Wed Feb 19 01:50:51 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Language | English |
| License | Copyright 2003 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 92:2196-2207, 2003 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3956-426a382e6f5a6a9fe5d33ed3edb1ec7064940d3b1c632e7da90110fcd60f3a6d2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 14603505 |
| PQID | 71332202 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_71332202 pubmed_primary_14603505 |
| PublicationCentury | 2000 |
| PublicationDate | November 2003 |
| PublicationDateYYYYMMDD | 2003-11-01 |
| PublicationDate_xml | – month: 11 year: 2003 text: November 2003 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of pharmaceutical sciences |
| PublicationTitleAlternate | J Pharm Sci |
| PublicationYear | 2003 |
| References | J Pharm Sci. 2004 Jul;93(7):1940 |
| References_xml | – reference: - J Pharm Sci. 2004 Jul;93(7):1940 |
| SSID | ssj0006055 |
| Score | 1.9958097 |
| Snippet | Finite element model (FEM) solutions of the diffusion through two-dimensional representations of the stratum corneum (SC) lipid pathway are presented. Both... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 2196 |
| SubjectTerms | Algorithms Animals Diffusion Finite Element Analysis In Vitro Techniques Lipid Metabolism Mice Models, Statistical Regression Analysis Skin - metabolism |
| Title | Steady-state flux and lag time in the stratum corneum lipid pathway: results from finite element models |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/14603505 https://www.proquest.com/docview/71332202 |
| Volume | 92 |
| WOSCitedRecordID | wos000186556800006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAMrDwfpTnDYiJqGncxg1CQgiBGKDqAKhb5fjsKqikhVCg_567pKETYkCKksWRIvty_s7f3XdCHKNDbCgXe0ibvdfQvvM0RugpXztmvQKTM7pPd6rdbnW7UWdOnJe1MJxWWfrE3FHj0PAZeY2DqYAi9YvRq8c9o5hbnTbQmBcVSUCGbVp1Z1rhBNSbP1rhFAaVukJ-UHseZTm5Gf6OK_P95Wblf1-2KpanuBIuC0NYE3M2XRcnnUKYenIKD7M6q-wUTqAzk6yebIg-p_XixMvLi8ANxl-gU4SB7gM3n4ckBQKKkGvsjl-AItbU0nOQjBIEbmr8qSdnQJH7ePCeAZesgEsYzYIt0tMh77iTbYrHm-uHq1tv2oLBM5IVCmn_1rIV2NA1dagjZ5sopUW64ro1ivBM1PBRxnUTysAq1FzJ6juDoe-kDjHYEgvpMLU7AnxDix8qE6KNGrYVtZSJpaNhMfkEF6iqOCqnt0cmzryFTu1wnPXKCa6K7WKFeqNCiYPjFmZGm7t_vrsnloo0PD482RcVRz-3PRCL5uM9yd4Oc8uhe7tz_w2eK9Ej |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Steady-state+flux+and+lag+time+in+the+stratum+corneum+lipid+pathway%3A+results+from+finite+element+models&rft.jtitle=Journal+of+pharmaceutical+sciences&rft.au=Frasch%2C+H+Frederick&rft.au=Barbero%2C+Ana+M&rft.date=2003-11-01&rft.issn=0022-3549&rft.volume=92&rft.issue=11&rft.spage=2196&rft_id=info:doi/10.1002%2Fjps.10466&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3549&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3549&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3549&client=summon |